SNDL Inc. (SNDL)
NASDAQ: SNDL · Real-Time Price · USD
2.140
+0.120 (5.94%)
At close: Aug 13, 2025, 4:00 PM
2.130
-0.010 (-0.47%)
After-hours: Aug 13, 2025, 7:59 PM EDT

G1 Therapeutics Revenue

SNDL Inc. had revenue of 244.77M CAD in the quarter ending June 30, 2025, with 7.30% growth. This brings the company's revenue in the last twelve months to 944.25M, up 3.55% year-over-year. In the year 2024, SNDL Inc. had annual revenue of 920.45M with 1.26% growth.

Revenue (ttm)
944.25M CAD
Revenue Growth
+3.55%
P/S Ratio
0.76
Revenue / Employee
362,617 CAD
Employees
2,604
Market Cap
550.73M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024920.45M11.44M1.26%
Dec 31, 2023909.01M196.81M27.63%
Dec 31, 2022712.20M656.07M1,168.88%
Dec 31, 202156.13M-4.79M-7.86%
Dec 31, 202060.92M-2.64M-4.16%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Feb 28, 2018 Pro Pro Pro
Feb 28, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition